Learn More
Medchemexpress LLC Solcitinib | 1206163-45-2 | 99.5% | 389.45 | 250 MG

Supplier: Medchemexpress LLC 250MGHY16755
Solcitinib is an orally active, competitive, potent, and selective JAK1 inhibitor with an IC50 of 9.8 nM. It exhibits 11-, 55-, and 23-fold selectivity over JAK2, JAK3, and TYK2, respectively, and is used in the research of moderate-to-severe plaque-type psoriasis.
- Orally active
- Competitive, potent, and selective JAK1 inhibitor
- High selectivity over JAK2, JAK3, and TYK2
- Used in research for moderate-to-severe plaque-type psoriasis
- Available in solid and solution forms
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.